Dahai Dong

585 total citations
20 papers, 447 citations indexed

About

Dahai Dong is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dahai Dong has authored 20 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dahai Dong's work include Ferroptosis and cancer prognosis (4 papers), Renal cell carcinoma treatment (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Dahai Dong is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Renal cell carcinoma treatment (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Dahai Dong collaborates with scholars based in China. Dahai Dong's co-authors include Guiming Zhang, Lijiang Sun, Yonghua Wang, Xiaokun Yang, Jun Zhao, Lingling Sun, Lei Luo, Wen Liu, Yongfang Jiang and Jirong Wang and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and European Spine Journal.

In The Last Decade

Dahai Dong

19 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dahai Dong China 13 218 177 129 107 100 20 447
Jun‐Long Song China 13 90 0.4× 143 0.8× 69 0.5× 94 0.9× 158 1.6× 30 432
Sohachi Nanjo Japan 12 314 1.4× 138 0.8× 149 1.2× 74 0.7× 194 1.9× 38 540
Huiyue Dong China 14 302 1.4× 158 0.9× 76 0.6× 60 0.6× 65 0.7× 20 485
Michiel F.G. de Maat Netherlands 11 273 1.3× 114 0.6× 93 0.7× 128 1.2× 128 1.3× 14 491
Zhenqiang Gao China 10 155 0.7× 83 0.5× 96 0.7× 67 0.6× 46 0.5× 26 344
Dongliang Xu China 14 191 0.9× 92 0.5× 109 0.8× 117 1.1× 104 1.0× 28 518
Hideaki Mizutani Japan 9 291 1.3× 225 1.3× 144 1.1× 166 1.6× 123 1.2× 25 579
Yunhua Lin China 9 209 1.0× 132 0.7× 74 0.6× 122 1.1× 36 0.4× 29 415
Jinna Wu China 9 128 0.6× 57 0.3× 61 0.5× 54 0.5× 45 0.5× 18 327

Countries citing papers authored by Dahai Dong

Since Specialization
Citations

This map shows the geographic impact of Dahai Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dahai Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dahai Dong more than expected).

Fields of papers citing papers by Dahai Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dahai Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dahai Dong. The network helps show where Dahai Dong may publish in the future.

Co-authorship network of co-authors of Dahai Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Dahai Dong. A scholar is included among the top collaborators of Dahai Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dahai Dong. Dahai Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Congsun, Xiaojun Ye, Feng Yao, et al.. (2025). Fate reversal: Exosome-driven macrophage rejuvenation and bacterial-responsive drug release for infection immunotherapy in diabetes. Journal of Controlled Release. 382. 113730–113730. 7 indexed citations
3.
Dong, Dahai, et al.. (2021). Cancer-Associated Fibroblasts Regulate Bladder Cancer Invasion and Metabolic Phenotypes through Autophagy. Disease Markers. 2021. 1–8. 19 indexed citations
4.
Wang, Jirong, et al.. (2020). Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer. International Immunopharmacology. 90. 107146–107146. 48 indexed citations
5.
Dong, Dahai, et al.. (2020). Elucidation of the Mechanism by Which a ADAMTS5 Gene MicroRNA-Binding Site Single Nucleotide Polymorphism Affects the Risk of Osteoarthritis. Genetic Testing and Molecular Biomarkers. 24(8). 467–477. 7 indexed citations
6.
Liu, Jing, et al.. (2020). Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma. International Immunopharmacology. 81. 106274–106274. 46 indexed citations
8.
Liu, Wen, et al.. (2018). Sex Differences in the Association between Night Shift Work and the Risk of Cancers: A Meta-Analysis of 57 Articles. Disease Markers. 2018. 1–20. 35 indexed citations
9.
Liu, Yuan, et al.. (2018). Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression. Cancer Biomarkers. 21(4). 915–923. 12 indexed citations
10.
Zhang, Guiming, et al.. (2018). MCT1 regulates aggressive and metabolic phenotypes in bladder cancer. Journal of Cancer. 9(14). 2492–2501. 53 indexed citations
11.
Dong, Dahai, et al.. (2018). Protective effects of the AKT activator SC79 on renal ischemia-reperfusion injury.. PubMed. 11(9). 4571–4578. 3 indexed citations
12.
Zhang, Guiming, et al.. (2016). MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma. Molecular Medicine Reports. 13(6). 5029–5036. 17 indexed citations
13.
Xu, Sheng, Guiming Zhang, Dahai Dong, et al.. (2015). The association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China. World Journal of Surgical Oncology. 13(1). 236–236. 15 indexed citations
14.
Zhu, Yao, et al.. (2015). The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy. Asian Journal of Andrology. 17(5). 839–839. 16 indexed citations
15.
Zhang, Guiming, Chengyuan Gu, Yao Zhu, et al.. (2015). ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma. Cancer Science. 106(6). 687–691. 19 indexed citations
16.
Zhang, Guiming, Yao Zhu, Dahai Dong, et al.. (2014). Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?. OncoTargets and Therapy. 7. 2043–2043. 8 indexed citations
17.
Zhao, Jun, Dahai Dong, Lingling Sun, Guiming Zhang, & Lijiang Sun. (2014). Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer. International braz j urol. 40(2). 179–189. 64 indexed citations
18.
Wang, Xinsheng, et al.. (2013). Clusterin Plays an Important Role in Clear Renal Cell Cancer Metastasis. Urologia Internationalis. 92(1). 95–103. 16 indexed citations
19.
Dong, Dahai, et al.. (2007). Association between the -1306C/T polymorphism of matrix metalloproteinase-2 gene and lumbar disc disease in Chinese young adults. European Spine Journal. 16(11). 1958–1961. 47 indexed citations
20.
Zhou, Tong, et al.. (2000). Effect of anti-P-selectin monoclonal antibody on renal ischemia/reperfusion injury in rats.. PubMed. 113(9). 790–3. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026